These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17569881)

  • 1. A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia.
    Avis HJ; Vissers MN; Stein EA; Wijburg FA; Trip MD; Kastelein JJ; Hutten BA
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1803-10. PubMed ID: 17569881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin.
    de Jongh S; Ose L; Szamosi T; Gagné C; Lambert M; Scott R; Perron P; Dobbelaere D; Saborio M; Tuohy MB; Stepanavage M; Sapre A; Gumbiner B; Mercuri M; van Trotsenburg AS; Bakker HD; Kastelein JJ;
    Circulation; 2002 Oct; 106(17):2231-7. PubMed ID: 12390953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease.
    Stein EA; Dufour R; Gagne C; Gaudet D; East C; Donovan JM; Chin W; Tribble DL; McGowan M
    Circulation; 2012 Nov; 126(19):2283-92. PubMed ID: 23060426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia.
    Stein EA; Marais AD; Szamosi T; Raal FJ; Schurr D; Urbina EM; Hopkins PN; Karki S; Xu J; Misir S; Melino M
    J Pediatr; 2010 Feb; 156(2):231-6.e1-3. PubMed ID: 19879596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis.
    Radaelli G; Sausen G; Cesa CC; Santos FS; Portal VL; Neyeloff JL; Pellanda LC
    Arq Bras Cardiol; 2018 Dec; 111(6):810-821. PubMed ID: 30365601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins for children with familial hypercholesterolemia.
    Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006401. PubMed ID: 25054950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with heterozygous familial hypercholesterolemia.
    Arai H; Teramoto T; Daida H; Ikewaki K; Maeda Y; Nakagomi M; Shirakawa M; Kakikawa T; Numaguchi H; Johnson-Levonas AO; Vaidya S; Blaustein RO
    Atherosclerosis; 2016 Jun; 249():215-23. PubMed ID: 27131642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.
    Huijgen R; Abbink EJ; Bruckert E; Stalenhoef AF; Imholz BP; Durrington PN; Trip MD; Eriksson M; Visseren FL; Schaefer JR; Kastelein JJ;
    Clin Ther; 2010 Apr; 32(4):615-25. PubMed ID: 20435231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.
    Wiegman A; Hutten BA; de Groot E; Rodenburg J; Bakker HD; Büller HR; Sijbrands EJ; Kastelein JJ
    JAMA; 2004 Jul; 292(3):331-7. PubMed ID: 15265847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Alirocumab in Japanese Patients With Heterozygous Familial Hypercholesterolemia or at High Cardiovascular Risk With Hypercholesterolemia Not Adequately Controlled With Statins　- ODYSSEY JAPAN Randomized Controlled Trial.
    Teramoto T; Kobayashi M; Tasaki H; Yagyu H; Higashikata T; Takagi Y; Uno K; Baccara-Dinet MT; Nohara A
    Circ J; 2016 Aug; 80(9):1980-7. PubMed ID: 27452202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins for children with familial hypercholesterolemia.
    Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E; Ramaswami U
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.
    Ballantyne CM; Shah S; Sapre A; Ashraf TB; Tobias SC; Sahin T; Ye P; Dong Y; Sheu WH; Kang DH; Ferreira Rossi PR; Moiseeva Y; Briones IR; Johnson-Levonas AO; Mitchel YB
    Am J Cardiol; 2017 Aug; 120(4):569-576. PubMed ID: 28624096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline lipid values partly determine the response to high-dose simvastatin in patients with familial hypercholesterolemia. The examination of probands and relatives in Statin studies with familial hypercholesterolemia (ExPRESS FH).
    de Sauvage Nolting PR; Buirma RJ; Hutten BA; Kastelein JJ;
    Atherosclerosis; 2002 Oct; 164(2):347-54. PubMed ID: 12204807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mipomersen, an apolipoprotein B synthesis inhibitor, on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia.
    Akdim F; Visser ME; Tribble DL; Baker BF; Stroes ES; Yu R; Flaim JD; Su J; Stein EA; Kastelein JJ
    Am J Cardiol; 2010 May; 105(10):1413-9. PubMed ID: 20451687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are treatment targets for hypercholesterolemia evidence based? Systematic review and meta-analysis of randomised controlled trials.
    Lebenthal Y; Horvath A; Dziechciarz P; Szajewska H; Shamir R
    Arch Dis Child; 2010 Sep; 95(9):673-80. PubMed ID: 20515970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.
    Raal F; Scott R; Somaratne R; Bridges I; Li G; Wasserman SM; Stein EA
    Circulation; 2012 Nov; 126(20):2408-17. PubMed ID: 23129602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Predicting Statin Initiation During Childhood in Familial Hypercholesterolemia: Importance of Genetic Diagnosis.
    Peretti N; Vimont A; Mas E; Ferrières J; Tounian P; Lemale J; Boccara F; Di Filippo M; Charriere S; Moulin P; Poinsot P; Cottin Y; Ducluzeau PH; Dourmap C; Cariou B; Farnier M; Paillard F; Pradignac A; Yelnik C; Gallo A; Bruckert E; Beliard S;
    J Pediatr; 2023 Feb; 253():18-24.e2. PubMed ID: 36049522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of mipomersen, an antisense inhibitor of apolipoprotein B, in hypercholesterolemic subjects receiving stable statin therapy.
    Akdim F; Stroes ES; Sijbrands EJ; Tribble DL; Trip MD; Jukema JW; Flaim JD; Su J; Yu R; Baker BF; Wedel MK; Kastelein JJ
    J Am Coll Cardiol; 2010 Apr; 55(15):1611-8. PubMed ID: 20378080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher.
    Ginsberg HN; Rader DJ; Raal FJ; Guyton JR; Baccara-Dinet MT; Lorenzato C; Pordy R; Stroes E
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):473-483. PubMed ID: 27618825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial.
    Ridker PM; Genest J; Boekholdt SM; Libby P; Gotto AM; Nordestgaard BG; Mora S; MacFadyen JG; Glynn RJ; Kastelein JJ;
    Lancet; 2010 Jul; 376(9738):333-9. PubMed ID: 20655105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.